Coya Therapeutics Ownership 2024 | Who Owns Coya Therapeutics Now?

Overview RevenueFinancials Chart

Institutional Ownership

42.54%

Insider Ownership

7.63%

Retail Ownership

49.83%

Institutional Holders

7.00

Coya Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AIGH CAPITAL MANAGEMENT LLC	21.62%	0.82%	560,000	-	-	2,220,546,000	Mar 31, 2023
GREENLIGHT CAPITAL INC	15.16%	0.08%	392,647	203	0.05%	1,560,183,000	Mar 31, 2023
WORTH VENTURE PARTNERS, LLC	5.32%	0.26%	137,758	-	-	542,767,000	Mar 31, 2023
BLACKROCK INC.	0.30%	-	7,727	7,727	100.00%	30,703,000	Mar 31, 2023
UBS GROUP AG	0.11%	-	2,846	1,631	134.24%	11,310,000	Mar 31, 2023
TRADITION WEALTH MANAGEMENT, LLC	0.03%	0.00%	849	849	100.00%	3,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	22	22	100.00%	87,000	Mar 31, 2023

Coya Therapeutics's largest institutional shareholder is AIGH CAPITAL MANAGEMENT LLC, holding 21.62% of the company's total share outstanding, currently valued at $2.22B. The top 10 institutional shareholders own together 42.54% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AIGH CAPITAL MANAGEMENT LLC	21.62%	0.82%	560,000	-	-	2,220,546,000	Mar 31, 2023
WORTH VENTURE PARTNERS, LLC	5.32%	0.26%	137,758	-	-	542,767,000	Mar 31, 2023
GREENLIGHT CAPITAL INC	15.16%	0.08%	392,647	203	0.05%	1,560,183,000	Mar 31, 2023
TRADITION WEALTH MANAGEMENT, LLC	0.03%	0.00%	849	849	100.00%	3,000	Mar 31, 2023
UBS GROUP AG	0.11%	-	2,846	1,631	134.24%	11,310,000	Mar 31, 2023
BLACKROCK INC.	0.30%	-	7,727	7,727	100.00%	30,703,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	22	22	100.00%	87,000	Mar 31, 2023

The largest Coya Therapeutics shareholder by % of total assets is AIGH CAPITAL MANAGEMENT LLC. The company owns 560.00K shares of Coya Therapeutics (COYA), representing 0.82% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	0.30%	-	7,727	7,727	100.00%	30,703,000	Mar 31, 2023
UBS GROUP AG	0.11%	-	2,846	1,631	134.24%	11,310,000	Mar 31, 2023
TRADITION WEALTH MANAGEMENT, LLC	0.03%	0.00%	849	849	100.00%	3,000	Mar 31, 2023
GREENLIGHT CAPITAL INC	15.16%	0.08%	392,647	203	0.05%	1,560,183,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	22	22	100.00%	87,000	Mar 31, 2023
WORTH VENTURE PARTNERS, LLC	5.32%	0.26%	137,758	-	-	542,767,000	Mar 31, 2023
AIGH CAPITAL MANAGEMENT LLC	21.62%	0.82%	560,000	-	-	2,220,546,000	Mar 31, 2023

As of Mar 31 2023, Coya Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 7.73K stocks of COYA, valued at $30.70M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AIGH CAPITAL MANAGEMENT LLC	21.62%	0.82%	560,000	-	-	2,220,546,000	Mar 31, 2023
WORTH VENTURE PARTNERS, LLC	5.32%	0.26%	137,758	-	-	542,767,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	22	22	100.00%	87,000	Mar 31, 2023
GREENLIGHT CAPITAL INC	15.16%	0.08%	392,647	203	0.05%	1,560,183,000	Mar 31, 2023
TRADITION WEALTH MANAGEMENT, LLC	0.03%	0.00%	849	849	100.00%	3,000	Mar 31, 2023
UBS GROUP AG	0.11%	-	2,846	1,631	134.24%	11,310,000	Mar 31, 2023
BLACKROCK INC.	0.30%	-	7,727	7,727	100.00%	30,703,000	Mar 31, 2023

As of Mar 31 2023, Coya Therapeutics's biggest institutional seller is AIGH CAPITAL MANAGEMENT LLC. The company sold 0.00 shares of COYA, valued at $2.22B.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLACKROCK INC.	0.30%	-	7,727	7,727	100.00%	30,703,000	Mar 31, 2023
TRADITION WEALTH MANAGEMENT, LLC	0.03%	0.00%	849	849	100.00%	3,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	22	22	100.00%	87,000	Mar 31, 2023

Coya Therapeutics's largest new institutional shareholder by number of shares is BLACKROCK INC., purchased 7.73K shares, valued at $30.70M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Coya Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
USAA MUTUAL FUNDS TRUST	0.00%	886	-	-	Jan 31, 2024

Coya Therapeutics's largest mutual fund holder by % of total assets is "USAA MUTUAL FUNDS TRUST", owning 886.00 shares, compromising 0.00% of its total assets.

Coya Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	7	75.00%
31 Dec, 22	4	-

As of 31 Mar 23, 7 institutions are holding Coya Therapeutics's shares, representing an increase of 75.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	1,101,849	0.96%
31 Dec, 22	1,091,417	-

Coya Therapeutics (COYA) has 1.10M shares outstanding as of 31 Mar 23, up 0.96% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	42.54%	0.95%
31 Dec, 22	42.14%	-

As of 31 Mar 23, Coya Therapeutics is held by 42.54% institutional shareholders, representing a 0.95% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	2	-
31 Dec, 22	-	-

2 institutional shareholders have increased their position in COYA stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	-	-
31 Dec, 22	-	-

- institutional shareholders have reduced their position in COYA stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	7	75.00%	1,101,849	0.96%	42.54%	0.95%	2	-	-	-
31 Dec, 22	4	-	1,091,417	-	42.14%	-	-	-	-	-

Coya Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Mar 05, 2024	Lee Ann	director	-	P-Purchase	Buy	1,000	$3.62	$3.62K	17,479

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Mar 05, 2024	Lee Ann	director	-	P-Purchase	Buy	1,000	$3.62	$3.62K	17,479

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jun 05, 2024	SNYDER DAVID S	officer	Chief Financial Officer	A-Award	Buy	70,596	$8.15	$575.36K	70,596
Jun 05, 2024	Berman Howard	director, officer	Chief Executive Officer	A-Award	Buy	163,663	$8.15	$1.33M	163,663
Jun 05, 2024	Grossman Fred	officer	Chief Medical Officer	A-Award	Buy	70,596	$8.15	$575.36K	70,596
Mar 05, 2024	Lee Ann	director	-	P-Purchase	Buy	1,000	$3.62	$3.62K	17,479
Feb 02, 2024	Grossman Fred	officer	Chief Medical Officer	A-Award	Buy	81,819	$5.90	$482.73K	81,819
Feb 02, 2024	Grossman Fred	officer	Chief Medical Officer	A-Award	Buy	74,069	$5.90	$437.01K	74,069
Feb 02, 2024	SNYDER DAVID S	officer	Chief Financial Officer	A-Award	Buy	81,819	$5.90	$482.73K	81,819
Feb 02, 2024	Berman Howard	director, officer	Chief Executive Officer	A-Award	Buy	189,680	$5.90	$1.12M	189,680
Jan 19, 2024	Weinand Dieter	director	-	A-Award	Buy	5,000	$7.41	$37.05K	5,000
Jan 19, 2024	Garren Hideki	director	-	A-Award	Buy	5,000	$7.41	$37.05K	5,000
Jan 19, 2024	GOLDSTEIN DOV A MD	director	-	A-Award	Buy	5,000	$7.41	$37.05K	5,000
Jan 19, 2024	Lee Ann	director	-	A-Award	Buy	5,000	$7.41	$37.05K	5,000
Jan 19, 2024	Villalobos Anabella	director	-	A-Award	Buy	5,000	$7.41	$37.05K	5,000
Jan 04, 2024	ROSS WILBUR L JR	director	-	A-Award	Buy	10,000	$6.97	$69.70K	10,000
Dec 29, 2023	ROSS WILBUR L JR	director	-		Buy	-	-	-	165,016
Aug 21, 2023	Weinand Dieter	director	-	A-Award	Buy	10,000	$3.43	$34.30K	10,000
Aug 21, 2023	Weinand Dieter	director			Buy	-	-	-	-
Jul 19, 2023	Grossman Fred	officer	Chief Medical Officer	A-Award	Buy	74,069	$4.25	$314.79K	74,069
Jul 19, 2023	Grossman Fred	officer	-		Buy	-	-	-	-
Mar 01, 2023	Berman Howard	director, officer	Chief Executive Officer	A-Award	Buy	165,000	$3.85	$635.25K	165,000

The last insider buy of COYA was made by Lee Ann on Mar 05 2024, buying 1,000 shares at $3.62 per share (worth $3.62K).

Coya Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	3	-	-
Q1 2024	10	-	-
Q4 2023	-	-	-
Q3 2023	3	-	-
Q1 2023	18	1	1800.00%
Q4 2022	-	4	-
Q2 2022	-	1	-
Q3 2021	-	1	-
Q2 2021	-	1	-

3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Coya Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	1	-	-
Q1 2023	14	-	-
Q4 2022	-	-	-
Q2 2022	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Coya Therapeutics's stocks.

Coya Therapeutics Peer Ownership

Ticker	Company
CUE	Cue Biopharma, Inc.
CNTA	Centessa Pharmaceuticals plc
TCRX	TScan Therapeutics, Inc.
DAWN	Day One Biopharmaceuticals, Inc.
HLVX	HilleVax, Inc.
STRO	Sutro Biopharma, Inc.
FENC	Fennec Pharmaceuticals Inc.
GANX	Gain Therapeutics, Inc.
DRMA	Dermata Therapeutics, Inc.
TERN	Terns Pharmaceuticals, Inc.
INZY	Inozyme Pharma, Inc.
LTRN	Lantern Pharma Inc.
ABOS	Acumen Pharmaceuticals, Inc.
INAB	IN8bio, Inc.
TFFP	TFF Pharmaceuticals, Inc.
CGTX	Cognition Therapeutics, Inc.
LIFE	aTyr Pharma, Inc.
OPT	Opthea Limited
ELYM	Eliem Therapeutics, Inc.
GRTX	Galera Therapeutics, Inc.

COYA Ownership FAQ

Who Owns Coya Therapeutics?

Coya Therapeutics is owned by institutional shareholders (42.54%), insiders (7.63%), and public (49.83%). The largest institutional shareholder of Coya Therapeutics is AIGH CAPITAL MANAGEMENT LLC (21.62% of total shares) and the top mutual fund owner is USAA MUTUAL FUNDS TRUST (0.00% of total shares).

Who are the major institutional shareholders of Coya Therapeutics?

Coya Therapeutics's major institutional shareholders are AIGH CAPITAL MANAGEMENT LLC, GREENLIGHT CAPITAL INC, WORTH VENTURE PARTNERS, LLC, BLACKROCK INC., and UBS GROUP AG. The top five shareholders own together 42.51% of the company's share outstanding.

How many Coya Therapeutics shareholders are there?

As of Mar 2023, there are 7 institutional shareholders of Coya Therapeutics.

What percentage of Coya Therapeutics is owned by AIGH CAPITAL MANAGEMENT LLC?

AIGH CAPITAL MANAGEMENT LLC owns 560K shares of Coya Therapeutics, representing 21.62% of the company's total shares outstanding, valued at $2.22B (as of Mar 2023).

What percentage of Coya Therapeutics is owned by GREENLIGHT CAPITAL INC?

As of Mar 2023, GREENLIGHT CAPITAL INC holds 392.65K shares of Coya Therapeutics (COYA), compromising 15.16% of the company, valued at $1.56B.

What percentage of Coya Therapeutics is owned by WORTH VENTURE PARTNERS, LLC?

WORTH VENTURE PARTNERS, LLC is the third largest holder of Coya Therapeutics. The company owns 137.76K of the company's shares outstanding (worth $542.77M).